Time Left to Bid
No deadline
OpenHealthcare & MedicalFederal
Basic information
- Reference number
- 90827-2026
- Issuing organization
- N/A
- Government level
- Federal
- Solicitation type
- Healthcare & Medical
- Title
- Suministro de tratamiento con Adalimumab Ploma/Xeringa
- Source
- TED (EU)
- Source ID
- 90827-2026
Details
- Location
- ES, European Union
Summary
Prórroga de un año para el contrato de suministro de inicios de tratamiento con Adalimumab Ploma/Xeringa en centros del Consorci Sanitari Integral. Adjudicado a Biogen Spain, S.L.
One-year extension of the contract for supply of Adalimumab medical products (Ploma/Xeringa) for healthcare centers of Consorci Sanitari Integral. Awarded to Biogen Spain, S.L.
Dates
- Publication
- 2026/02/09 12:00:00 AM UTC
- Closing date
- N/A
Estimated value
$26K – $614K EUR
How to bid
Classification
Normalized category
Healthcare & Medical